tirzepatide and sleep apnea for Obstructive Obesity VisualAbstract: Tirzepatide Improved Outcomes in

Eli Lilly delivered a Q1 2026 trifectaearnings beat, raised full-year guidance, and early-April FDA approval of Foundayo, the first oral GLP-1 with no food or water restrictionswidening its lead over Novo Nordisk just as the race for a convenient weight-loss pill heats up

Cardialen has announced the publication of a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology investigating its low-voltage MultiPulse therapy to terminate atrial fibrillation (AF)

Additional Ivim Health GLP-1 program information is available through the sellers website What Is Ivim Health GLP-1

Women should mention if they are pregnant, breastfeeding, or planning to become pregnant